Company intelligence / Profile preview

Abingworth Management

London, United Kingdom

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Abingworth is a leading transatlantic life science investment firm focused on funding and guiding biotherapeutics, especially in clinical and pivotal stages, and has supported over 185 life science companies resulting in more than 75 IPOs and 50+ M&As.[10][3]

Modalities: Small moleculeMonoclonal antibodyNucleic acid therapeuticsVaccineGene therapyCell therapyBiologic
Industry: Investors

Partnerships

Pfizer (via Avillion clinical co-development partnership for Bosulif)[3]Numerous partnerships through its portfolio companies

Beyond the preview

Go deeper on Abingworth Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abingworth Management.

Explore the full profile